Khavinson Bioregulators: The Complete Guide
Last updated: March 2026
Ultra-short peptides that skip surface receptors and talk directly to DNA. Here's the complete breakdown of all 11 bioregulators, how to stack them, and why they work differently from everything else.
by Khavinson's Team
Russian Program
Cataloged Here
📋 On this page
Not Like Other Peptides
Most peptides bind surface receptors. Khavinson bioregulators do something fundamentally different — and that's why they've attracted 40+ years of research.
- Bind cell surface receptors (GPCR, tyrosine kinase, etc.)
- Trigger signaling cascade inside cell
- Signal degrades — effect fades when peptide clears
- Downstream effects only — can't directly change gene expression
- Examples: BPC-157, TB-500, GLP-1, GH secretagogues
- Ultra-short (2–4 amino acids) — pass through cell membrane
- Enter cell nucleus directly
- Interact with DNA promoter regions and histones
- Regulate gene expression at the source
- Effect can persist after peptide is cleared (epigenetic)
- Examples: Epitalon (AEDG), Pinealon (EDR), Vilon (KE)
All 11 Khavinson Bioregulators
Each bioregulator targets a specific organ system. This is organ-specific medicine at the peptide level — one compound, one target.
Stacking Guide
Khavinson's research program used multiple bioregulators simultaneously. Here are the most studied and rationally designed combinations. Note: No human RCT data exists for most of these stacks specifically.
Cycling Protocol
Unlike traditional peptides with daily continuous use, bioregulators are typically cycled — matching how Khavinson's research program was structured.
Oral Bioavailability of Ultra-Short Peptides
Most peptides are destroyed by stomach acid and gut enzymes. Bioregulators survive — and this is why.
Traditional peptides (15–40+ amino acids) are large enough that proteases cleave them into individual amino acids before absorption. The biological signal is destroyed in transit.
Khavinson bioregulators are ultra-short (2–4 amino acids) — small enough to be transported intact across the intestinal epithelium by dedicated peptide transporters (PEPT1 and PEPT2). These transporters evolved to absorb short nutritional peptides — bioregulators exploit the same system.
This is why oral doses are higher than injectable doses (lower bioavailability is compensated with higher dose) but the oral route is still effective. The 72-patient TBI trial used oral Pinealon — demonstrating clinically meaningful effects via this route.
🛒 Recommended Supplies
Essential supplies for peptide research. For injectable protocols, these are the basics.
Affiliate links help support HighPeptides at no extra cost to you.
Self-Assessment
Who Researches Bioregulators?
This Research Is Commonly Explored By People Who...
- Are interested in Khavinson peptide bioregulators and their proposed gene expression regulation mechanisms
- Want to understand the Russian clinical research on short peptides (2-4 amino acids) for organ-specific effects
- Are exploring longevity and anti-aging research beyond mainstream Western approaches
- Want to learn about epithalamin, vilon, cortagen, and other organ-specific bioregulators
- Are curious about the intersection of peptide therapy and epigenetic regulation
This Research May Not Be Relevant If...
- You expect Western-standard randomized controlled trials — most bioregulator data comes from Russian military and clinical research
- You're looking for acute symptom treatment — bioregulators are studied as long-term, course-based interventions
- You want widely available, pharmacy-dispensed medications — most bioregulators are specialty peptide products
Want the Complete Protocol Guide?
Dosing schedules, interaction warnings, and cycle protocols for 50+ compounds — all in one place.
Get the Guide →
Compound-Specific Research Pages
🔗 Related Resources
Research-Grade Peptides
Third-party tested compounds with certificates of analysis. Used by researchers worldwide.
Browse Swiss Chems →Affiliate link — supports HighPeptides at no extra cost.
This page is for educational and informational purposes only. It is not medical advice, and nothing here should be interpreted as a recommendation to use any bioregulator peptide. None of the Khavinson bioregulators cataloged on this page are approved by the FDA or EMA for human use. They are research compounds. Russian clinical data, while extensive (15M patients, 40+ years, 6 approved Russian pharmaceuticals), has not been submitted for Western regulatory review under current RCT standards. Dosing information is derived from published research — not medical prescription. Always consult a qualified healthcare provider before making any health decisions. HighPeptides does not sell peptides or endorse their use outside of legitimate research settings.